Alembic Pharmaceuticals Ltd
Suhas Shinde is an experienced professional in the pharmaceutical industry, currently serving as Associate Vice President of QA at Alembic Pharmaceuticals Limited since March 2017. This role encompasses various responsibilities, including quality assurance, deviation management, quality risk management, and compliance with GMP standards. Prior to this position, Suhas held significant roles at Micro Labs Ltd., including General Manager and Sr. Manager of Analytical Development. With a strong foundation in organic chemistry and chemistry, obtained through an M.Sc. from Savitribai Phule Pune University, Suhas has developed expertise in analytical method validation, process validation, and product lifecycle management throughout a career that began at Lupin Research Park in 2002.
This person is not in any teams
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.